Angiotensin I-converting enzyme (ACE) is a key enzyme in the regulation of systemic blood pressure and plays a major role in the renin-angiotensin and bradykinin-kinin systems, at the luminal surface of the vascular endothelia. To identify the promoter region, the transcription regulatory elements and the cell specificity of the ACE gene, five successive DNA deletions of the 5' upstream region (-1214, -754, -472, -343, -132 bp relative to the start site of transcription) were isolated and fused in sense and antisense orientations to the bacterial chloramphenicol acetyltransferase (CAT) reporter gene in the promoterless plasmid pBLCAT3. Promoter activities were measured in transient transfection assays using three different cell lines from rabbit endothelium (RE), human embryocarcinoma (Tera-1) and hepatocarcinoma cells (HepG2). All five fragments of the ACE promoter region directed expression of the CAT gene when transfected into the endothelial and the embryocarcinoma cells,
INTRODUCTION
Angiotensin I-converting enzyme (ACE, peptidyl dipeptide hydrolase, EC 3.4.15.1) is a zinc metallopeptidase which plays an important role in blood pressure homoeostasis (Erdos and Skidgel, 1987; Ehlers and Riordan, 1990) . ACE converts angiotensin I into the potent vasoconstrictor angiotensin II and degrades bradykinin, a potent vasodilator (Yang et al., 1970) . ACE displays a wide substrate specificity, hydrolysing several other natural and synthetic peptides in vitro.
Two isoenzymes of ACE are found in mammalian tissues having molecular masses of 170 and 90 kDa, which correspond to the expression of two mRNAs of 4.3 and 3.0 kb respectively (Soubrier et al., 1988) . The larger isoenzyme is principally produced by the pulmonary vascular endothelium and by absorptive epithelia, such as the brush borders of the small intestine and kidney proximal convoluted tubules (Ward et al., 1980; Lieberman and Sastre, 1983; Bruneval et al., 1986) . The larger ACE isoenzyme is also present in neuroepithelial cells, monocytes and T lymphocytes (Defendini et al., 1983; Okabe et al., 1985; Costerousse et al., 1993) . The 90 kDa form is produced exclusively by germinal cells at the onset of puberty (El-Dorry et al., 1982; Lanzillo et al., 1985) . The expression of the two ACE isoenzymes is regulated in a tissue-specific fashion. Furthermore, the expression of germinal ACE is developmentally regulated, whereas the synthesis of somatic ACE is induced by glucocorticoids (Krulewitz et al., 1984) . The structural organization of the human ACE gene has been established (Hubert et al., 1991) and spans 21 kb, comprising 26 exons. The somatic ACE mRNA which contain endogenous ACE mRNA and express ACE activity. In contrast only minimal levels of promoter activity were obtained on transfection into hepatocarcinoma cells in which endogenous ACE mRNA and ACE activity were not detected. Transfection of RE and Tera-I cells demonstrated that promoter activity was defined by the length of the ACE promoter sequence inserted into the construct. The 132 bases located upstream from the transcription start site were sufficient to confer ACE promoter activity, whereas the sequences -upstream from -472 bp and between -343 bp and -132 bp were responsible for a decrease of promoter activity. Furthermore, the minimal 132 bp of the ACE promoter contains elements which direct cell-specific CAT expression. In addition, the DNA transfection study in the presence of dexamethasone suggested that the potential glucocorticoid regulatory elements, located in the sequence of the ACE promoter, are not functional.
(4.3 kb) is transcribed from exons 1 to 26, excluding exon 13 by differential splicing. In contrast, transcription of the germinal ACE mRNA (3 kb) is initiated within the gene at exon 13 and proceeds through exons 14 to 26. The different 5' ends of the two ACE transcripts, i.e. somatic and germinal, suggest the presence of two promoters in the gene (Hubert et al., 1991) . We have recently demonstrated the germinal ACE promoter activity in a teratocarcinoma cell line (Tera-l) derived from primary diploid germ cells, which express somatic ACE and very low levels of germinal ACE as detected by reverse-transcription PCR (RT-PCR) assays (Nadaud et al., 1992) . Alternative transcription start sites of the ACE gene have also been reported in both mice and rabbits (Howard et al., 1990; Kumar et al., 1991 Hubert et al., 1991) . To MATERIALS AND METHODS Constructions of ACE-CAT fusion plasmids A 1.5 kb PstI-PstI fragment ofthe human ACE subclone pHA6.5 (Hubert et al., 1991) , containing the 5' flanking region of the gene and part of the first exon, was isolated and digested by convenient restriction endonucleases for construction of expression vectors into the polylinker of the promoterless plasmid pBLCAT3 (Luckow and Schiitz, 1987 (Luckow and Schiitz, 1987) . These constructs were called pACE3.3tk-CAT and pACE2.2tk-CAT respectively. The deletion constructs and their orientations were confirmed by restriction mapping and dideoxy-chaintermination sequencing (Sanger et al., 1977 (Cushman and Cheung, 1971) . A specific ACE inhibitor, enalaprilat (1 1CM), was included in the control incubation (Merck, Sharp and Dohme). Protein concentration was determined by the Bradford method (Sedmak and Grossberg, 1977) . All enzymic studies were performed under initial rate conditions.
Isolation of RNA and RT-PCR
Total cellular RNA was isolated from different cell cultures using a guanidinium isothiocyanate/CsCl2 procedure, as described by Chirgwin et al. (1979) . RNA was quantified by measuring its absorbance at 260 nm.
Oligonucleotides, synthesized by a PCR-Mate 391 (Applied Biosystems), were designed according to the human ACE cDNA sequence (Soubrier et al., 1988) and sense primers, 1.25 mM of each dNTP, 5, l of reverse transcriptase product and 2 units ofTaq polymerase (BoehringerMannheim) for 30 cycles by a step programme (95 'C for 1 min, 55 'C for 1 min, 72 'C for 1 min), followed by a final 10 min extension at 72 'C. Amplification products were analysed by using 2 % (w/v) agarose gel electrophoresis and ethidium bromide staining. These products were then transferred to nylon Hybond N+ membrane (Amersham) and hybridized with a labelled oligonucleotide located within exon 14 of the ACE gene. Hybridization was carried out at 40 'C for 16 h in 6 x SSC
(1 x SSC is 150 mM NaCl, 15 mM sodium citrate, pH 7.0)/ 50 mM NaH2PO4/O.1 % SDS/5 x Denhardt's solution/100,ug/ ml of denatured salmon sperm DNA. The membrane was washed at 45 'C in 2 x SSC/G.1 0% SDS and autoradiographed using Kodak X-Omat film.
Cell transfections
Cell transfection of plasmid DNA was carried out by the calcium phosphate precipitation technique (Graham and Van der Eb, 1973) . Cells were plated on to 100-mm-diam. Petri dishes 24 h before transfection. The culture protocol was designed to transfect sub-confluent cells, to obtain confluent cultures when the cells were harvested. The medium was changed 3 h before transfection and replaced by DMEM medium (Gibco) containing sodium pyruvate and 10 % (v/v) fetal-calf serum. A total amount of 25,tg of DNA was added into each plate: 15 ,ug of tested plasmid and 10 ug of pRSVfl-galactosidase, which was used as an internal control to monitor transfection efficiency (Edlund et al., 1985) . For RE and HepG2 cells the calcium phosphate precipitates were left for 15 h at 37°C, then the cells were washed and fresh medium was added. The Tera-I cells were incubated Human somatic angiotensin I-converting enzyme promoter analysis for 4 h at 37°C in the presence of DNA-calcium phosphate.
After treating with 150% (v/v) glycerol for 2 min, the cultures were rinsed with DMEM and refed with growth medium. Cells were harvested by scraping 48 h after transfection. Transfections with pRSVCAT (Gorman et al., 1982) were performed as a 1000% positive control for expression in each cell type. For induction by glucocorticoids, after transfection cells were washed and refed with serum-free GT medium (Biochrom, Angouleme, France) supplemented with 4 x 10-8 M selenium and 5 x 10-7 M dexamethasone (Sigma) for 48 h. Each transfection experiment was repeated at least three times with at least two different plasmid preparations for each construct.
CAT assays
At 48 h after transfection, cells were harvested, resuspended in 250 mM Tris/HCl, pH 7.8, and lysates were prepared by three cycles of freeze-thawing. Cellular debris was removed by centrifugation. The resulting supernatants were assayed for ,-galactosidase and CAT activities. The /-galactosidase activity used to monitor transfection efficiency for each dish was assayed as described by Herbomel et al. (1984) . The ,-galactosidase activity was expressed as 10-2 x A420, extrapolated to 1 h of reaction time, for a total 200,tl of extract. The different extracts, containing equivalent ,-galactosidase units, were assayed for CAT activity after incubation at 65°C for 10 min (Crabb and Dixon, 1987) . The extracts used for CAT assay were analysed for acetylation of
[l4C]chloramphenicol (55 mCi/mmol, Amersham Corp.) in the presence of 4 mM acetyl-coenzyme A (Boehringer, Mannheim, Germany) and reactions were stopped by the addition of ethyl acetate. The acetylated and non-acetylated forms of chloramphenicol were separated by ascending chromatography on silica-gel plates using chloroform/methanol (95:5, v/v) as the mobile phase and were revealed by autoradiography as described by Gorman et al. (1982) . The extent of conversion of substrate into products was quantified by excising labelled spots and counting radioactivity in a liquid fl-scintillation counter. For quantification of CAT activity, the extract concentrations and the reaction times were selected to ensure linear conversion of the chloramphenicol into acetylated forms.
RNAase-protection assay A fragment of 319 bp from the pACE472-CAT, containing 46 bp of the ACE gene and 273 bp of the CAT gene, was amplified by PCR using 20-base-long forward and reverse primers. This fragment was subcloned into the plasmid vector Bluescript SKII, and sequenced in its entirety to confirm the absence of PCR-generated misincorporation. After linearization of the plasmid with HindlIl, transcription was performed in vitro in the presence of [a-32P]UTP and T3 RNA polymerase to synthesize labelled antisense RNA (Ausubel et al., 1987) . The radioactive probe was purified by gel electrophoresis and hybridized at 45°C overnight to RNA (50,g) prepared from cells transfected as described above. Unprotected RNA was digested by ribonuclease A (50 mg/ml) and TI (1500 units/ml) and then applied to a 5 % (w/v) acrylamide/7 M urea sequencing gel.
RESULTS
ACE activity and detection of somatic ACE mRNA by RT-PCR To study the suitability of cell lines for testing ACE promoter experiments in transfection assays, ACE activity was measured in immortalized RE, Tera-1 and HepG2 cell lines. ACE activity was determined using a synthetic substrate (Hip-His-Leu) in the absence and presence of 10-6 M enalaprilat to confirm the specificity of the reaction.
ACE activity was detected in the RE and Tera-I cell lines. In contrast, ACE activity was not detected in HepG2 cells ( Figure   la ). The expression of endogenous ACE mRNA in each cell line was determined by an RT-PCR amplification method. Amplified fragments of the transcripts corresponded to the expected size (212 bp) for the ACE cDNA (Figure lb) . The fragment was specific to somatic ACE, since the primers used to amplify the cDNA were specific to the somatic transcript. This fragment hybridized to an oligonucleotide designed from the sequence of exon 14 ( Figure Ib) . ACE mRNA was detected in RE and Tera-l cells but was absent in HepG2 cells, consistent with the ACE activity assays.
Identification of the functional somatic ACE promoter region In the Immortalized endothelial cells To define further potential regulatory elements required for promoter activity, a series of mutants containing deletions between -1214 and -132 bp was constructed. A schematic diagram of these constructs is shown in Figure 2 (a). These constructs were transiently transfected into the RE cell line. Transfection efficiency was monitored by co-transfection with the pRSV,-galactosidase plasmid to normalize the CAT activity.
The pRSVCAT plasmid, a strong promoter active in most cells, was used as reference and was defined as 100 % of relative CAT activity. The results of these transfections are presented in Figure  2( substantial loss of activity of 46 %. Further deletion of 211 bp, leading to the pACE132-CAT, produced an equivalent relative CAT activity compared with the 472 bp fragment. The 132, 472 and 1214 bp fragments indicated relative CAT activities of 0.9 %, 1.2%, 0.8 % respectively, when inserted in the reverse orientation, and these values were close to the pBLCAT3 expression. Therefore, the major elements required for somatic ACE promoter activity in endothelial cells are located within the 132 bp upstream from the transcription start site. To elucidate whether RNA transcription from the pACE472-CAT construct involved the same initiation site as the ACE gene in the endothelial cell, a ribonuclease-protection assay was performed with the transfected ACE-CAT fusion gene. RNA from transfected cells was extracted and hybridized with a T3-promoter-driven radiolabelled antisense RNA probe. This probe was synthesized from a PCR-generated fragment (319 bp) spanning the transcription start site. The protected RNA fragment from transfected cells exhibited the expected size of approx. 294 bases when compared with DNA molecular-mass markers, demonstrating that the transcription fusion gene initiated at the authentic start site of the human ACE gene (Figure 3) . No protected fragments-were observed when yeast tRNA was used, thus confirming the specificity of the detection.
Cell specfflcity of the somatic ACE promoter
The ability of the ACE promoter region to confer cell specificity was tested by transfection of the CA T constructs into both Tera-1 and HepG2 cells. These cell lines were used since the Tera-I cells express high levels of endogenous ACE activity, whereas ACE activity and ACE mRNA cannot be detected in the HepG2 cells (Figure 1 ). The transfections of the constructs in Tera-1 cells displayed an overall high promoter activity, since the pACEE132-CAT expression was 4-fold higher than in RE cells (47 % versus 11.4%). The pACE132-CAT construct corresponded to the maximal promoter activity in Tera-1. The addition of a fragment of 340 bp (pACE472-CAT) produced a decrease of 230% of promoter activity and the further addition of 282 bp (pACE754-CAT) or 742 bp (pACE1214-CAT) indicated a continuous diminution in activity by 29% and 41 % respectively of the maximal activity (Figure 2b ). All the reverse-orientation inserts gave similar results to those of the promoterless pBLCAT3.
Thus, in a human cell line expressing a high level of ACE activity and ACE mRNA, a high promoter activity is present in all fragments studied.
In HepG2, the maximal activity compared with the pRSVCAT was only 4 % compared with 11 % and 47 % in RE and Tera-1 cells respectively. This value was less than the lowest CAT activity measured in endothelial cells (Figure 2 ). For all constructs, the relative CAT activities were close to the basal pBLCAT3 value.
No transcriptional response to glucocorticolds in fragments up to 3.6 kb In the 5' flanking region of the ACE gene Within the sequence of 1214 bp of 5' flanking region of the ACE gene, we noticed three potential glucocorticoid-responsive elements (GREs) at positions -935, -794 and -686 bp from the transcription start site (Hubert et al., 1991) . To test the functionality of the GRE sequences in RE cells, preliminary experiments were carried out with the plasmid pMAMneoCAT. This plasmid contains the GRE of the mouse mammary tumour virus long terminal repeat, which drives the expression of the CAT gene. RE cells were co-transfected with pMAMneoCAT and the expression vector of the human glucocorticoid receptor (pHGO) which gave a 18.7-fold induction by glucocorticoid (Table 1 ). The effect of dexamethasone (5 x 10-7 M) in a serumfree medium on the expression of the chimeric gene pACE1214-CAT was studied using glucocorticoid-induced RE cells. To minimize the variations of CAT expression between two separate calcium phosphate precipitates, the same DNA precipitate was used; one in the absence and one in the presence of gluco- Anti-RNA probe~1--396 nt fore two other DNA fragments, -3.6 and -2.5 kb upstream from the transcription start site, were analysed. Neither of these two fragments (-3.6 kb to -295 bp and -2.5 kb to -295 bp) in front of the tk promoter were stimulated by dexamethasone under conditions where the control, pMAMneoCAT, was induced. (Soubrier et al., 1988) . However, primary cultures of endothelial cells, as well as available human endothelial cell lines, do not transfect efficiently (P. Testut, unpublished work); therefore cell cultures from different species, for example bovine aortic endothelial cells, have been used to study the human preproendothelin-1 gene (Lee et al., 1991) or the human transcription factor GATA-2 protein (Dorfman et al., 1992) . The RE cell line has previously provided a useful model for biochemical studies of another zinc metalloprotease, neutral endopeptidase (EC 3.4.24.11) (Llorens-Cortes et al., 1992) . To evaluate if this efficiently transfectable cell line was suitable for the study of the ACE promoter, the presence of ACE mRNA and ACE activity was first confirmed. The transcription start site was analysed using transient transfection of a human ACE promoter linked to a CAT gene construct. A RNAase-protection assay confirmed that the site of the ACE-CAT fusion transcript was identical to the ACE mRNA initiation site in human endothelial cells (Hubert et al., 1991) . Transcription is one critical step at which regulation of gene expression might occur. To analyse the transcriptional regulation of the ACE gene, a series of 5' deletions of the somatic ACE promoter were performed and inserted upstream of the CAT reporter gene. Promoter activities were measured in transient transfection assays. In endothelial cells the 5' region of the ACE gene directed the transcription of the reporter CAT gene. The strength of the promoter activity depended on the length of the promoter inserted into the construct, which enabled us to identify various DNA regulatory regions. There are at least two positive and two negative cis-acting regions involved in the ACE promoter. The proximal region, within the first 132 bp upstream from the transcription start site, is sufficient to significantly produce CAT expression over the control promoterless vector. The orientation of this fragment was crucial, since transfection in the reverse direction resulted in a promoter activity equivalent to the pBLCAT3 plasmid. The activity of the proximal fragment was made possible by the presence of (a) a canonical TATA box located 41 bp upstream from the transcription start site and (b) three potential binding sites for the SPI factor Hubert et al., 1991) . The SPI factor is involved in the transcription of a large number of genes (Dynan and Tjian, 1985; Gumucio et al., 1991; Li et al., 1991; Meroni et al., 1991) . In the ACE promoter it should be noted that two SPI-binding sites are in phase on the same side of the helix which appeared to influence transcription of the adenovirus 2 earlylB promoter more efficiently in HeLa cells (Segal and Berk, 1991) .
ACE activity in Tera-1 cells was much higher than in the RE cell line, consistent with the higher overall promoter activity achieved in Tera-1 cells. However, the pattern of CATexpression was almost parallel, except for the first 132 bp construct where a marked enhancement of transcription activity was observed.
This increased activity may be due to the presence of transactivating factors expressed at higher levels in Tera-1 cells, the activation of alternative elements in the two cell types, or to a better recognition of nuclear proteins in a homologous human system (Somma et al., 1991; Paulweber et al., 1991) . In order to test the cell specificity of the ACE promoter, HepG2 cells were used as a model cell line which does not express ACE. We first confirmed that these cells do not contain measurable ACE activity or ACE mRNA after RT-PCR amplification. In transfection assays, irrespective of the length of the promoter tested, CAT activities were detected close to basal transcription, as commonly observed in experiments in vitro. The markedly reduced expression in HepG2 cells contrasts with the expression observed in RE cells, suggesting that cell-specific regulatory elements located in RE cells are within the first 132 bp upstream from the initiation start site. This is consistent with the hypothesis of the cell-specificity mechanism.
The potential GREs shown within the sequence of the ACE gene studied are not functional in transfection assays. Up to 3.6 kb from the transcription start site, no transcriptional enhancement was observed in the presence of dexamethasone. This result is in contrast with earlier reports (Krulewitz et al., 1984) . Two hypotheses could explain this discrepancy. First the GRE might be located elsewhere in the ACE gene, i.e. further upstream as described for a milk protein, whey acidic protein (WAP), where important hormonal regulatory elements are located between -6300 and -3000 bp upstream from the WAP transcription start site (Devinoy et al., 1991) ; or alternatively, the GRE might also be located within the gene, as for the 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase where it was located in the first intron of the gene (Lange et al., 1992) . Secondly, in experiments in vitro the observed induction by glucocorticoids of the ACE protein could be the consequence of the stabilization of ACE mRNA as established for other transcripts such as human growth hormone or phosphoenolpyruvate carboxykinase (Paek and Axel, 1987; Petersen et al., 1989) . This is the first study to demonstrate that the human somatic ACE promoter is controlled by a combination of both positive and negative regulatory elements located within the 5' flanking region, as has been previously described for several other genes, for example, the mouse multidrug resistance lb (mdr lb) gene, the rat ceruloplasmin and the human blood coagulation factor X (Cohen et al., 1991; Fleming and Gitlin, 1992; Huang et al., 1992) . Our results indicated that 132 bp upstream from the transcription start site of the ACE gene is sufficient for the promoter activation co-ordinated in an endothelial cell line. Further characterization of the A CE-promoter region and study of its interactions with nuclear transcription factors will increase our understanding of the genetic mechanisms that govern the expression of ACE in different cell types.
